Willow Biosciences Inc. (TSX:WLLW)

Market Cap	724.23K
Revenue (ttm)	4.66M
Net Income (ttm)	-6.19M
Shares Out	144.85M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,500
Average Volume	488,228
Open	0.0100
Previous Close	0.0050
Day's Range	0.0050 - 0.0100
52-Week Range	0.0050 - 0.1450
Beta	1.11
RSI	26.37
Earnings Date	May 9, 2025

About Willow Biosciences

Willow Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has licensing and development partnership with Laurus Labs to develop and commercialize active pharmaceutical ingredients and other ingredients. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2019
• Employees: 19
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: WLLW

Financial Performance

In 2024, Willow Biosciences's revenue was 4.66 million, an increase of 297.78% compared to the previous year's 1.17 million. Losses were -6.19 million, -52.50% less than in 2023.